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Purpose: To investigate the efﬁcacy of intraocular pressure (IOP) control and medication use over time
after trabeculectomy (TRBC) and Ex-PRESS shunt implantation in primary-open-angle-glaucoma (POAG)
patients.
Design: Retrospective case series.
Patients and methods: A total of 33 unilateral POAG patients were enrolled, and 17 patients received
traditional TRBC and 16 patients received Ex-PRESS device implantation. Data on IOP, reduction of
antiglaucoma medication, and major complications were collected and analyzed after 12 months of
follow up.
Results: After 12 months of follow up, both groups showed good IOP control. The mean preoperative IOP
decreased from 38.5 (±6.9) to 18.2 (±11) mmHg after TRBC, and from 38.5 (±9.1) to 19.53 (±12.36) mmHg
after Ex-PRESS implantation (both p < 0.05). The mean number of antiglaucoma medications prescribed
at the last follow up decreased from 3.2 (±0.5) preoperatively to 1.2 (±1.4) after TRBC versus 3.3 (±0.7)
preoperatively to 1 (±0.9) after Ex-PRESS implantation (both p < 0.05). Complete success rate (deﬁned as
no medication after surgery with IOP >5 and <18 mmHg) and qualiﬁed success rate (deﬁned as with or
without medication after surgery with IOP >5 and <18 mmHg) were similar (47% vs. 43% and 76.47% vs.
75%) between the two groups without statistical difference (p > 0.05). However, postoperative hypotony
rate was more frequent after Ex-PRESS (37.5%) than after TRBC (17.64%).
Discussion: TRBC and Ex-PRESS implantation provided similar IOP control and reduction of postoperative
medication with low incidence of postoperative complications at intermediate-term follow up. However,
the Ex-PRESS implantation device may last longer but with extra costs. It is up to the surgeon to decide
which procedure to use according to the patient's situation and economic circumstances.
Copyright © 2015, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Trabeculectomy (TRBC; Fig. 1A) has been widely used for more
than half a century for the control of intraocular pressure (IOP) in
patients with glaucoma.1 The success rate and complications of thisave no ﬁnancial and personal
d have inappropriately inﬂu-
ther personal interest of any
y that could be construed as
f, the manuscript.
logy, Show Chwan Memorial
. Chao).
ciety of Taiwan. Published by Elseprocedure have been well described; it is now known that the
complications of TRBC include hypotony, conjunctival erosions, and
choroidal detachment among other adverse effects.2 Thus, glau-
coma surgeons continue to search for improved methods that have
superior efﬁcacy and safety compared with TRBC.
The Ex-PRESS device was approved by the United States Food
and Drug Administration in 2002.3 This stainless steel device is
designed to be implanted adjacent to the limbus directly under a
scleral ﬂap (Fig. 1B) to allow drainage of aqueous humor into the
subconjunctival space provided there is a standardized lumen size
and reduced inﬂammationwith less tissuemanipulation3,4 (Fig.1C).
The relatively simple technique of implanting an Ex-PRESS valve is
similar to that used in standard TRBCwith one obvious exception of
not requiring a sclerectomy or peripheral iridectomy.vier Taiwan LLC. All rights reserved.
Fig. 1. (A) Patients received trabeculectomy with bleb formation. (B) Patients received Ex-PRESS shunt implantation with bleb formation. (C) Ex-PRESS shunt implantation provides
standardized lumen size and stable ﬁltering function.
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TRBC versus Ex-PRESS shunt implantation.
2. Methods and materials
We performed a retrospective, comparative case series study on
patients with primary open angle glaucoma (POAG) who had un-
dergone implantation of Ex-PRESS miniature glaucoma implant
under a scleral ﬂap or TRBC between March 2012 and March 2013
at a single center by a single experienced surgeon.
Wecollecteddata frompatientsolder than18yearswhopresented
with medically uncontrolled POAG requiring surgery for IOP reduc-
tion. Patientsmeetinganyof the followingcriteriawere excluded: any
form of glaucoma other than POAG, history of active uveitis, and any
previous ocular glaucoma surgery. Patients were evaluated on
postoperative Days 1, 3, 7, and 14, and at 1, 3, 6, 9, and 12 months.
Releasable sutures were removed 3 weeks postoperatively.
Data on the following clinical parameters were collected and
assessed at each clinical visit: surgical complications, IOP
(measured by calibrated Goldmann applanation tonometers), and
the number of antiglaucoma medications required to achieve
adequate IOP control. In order to compare the outcomes of TRBC
and Ex-PRESS shunt implantation, qualiﬁed success was deﬁned as
an IOP between 5 and 18 mmHg with or without medication, and
complete success was deﬁned as an IOP between 5 and 18 mmHg
without medication. Treatment failure was deﬁned as an IOP <5 or
>21 mmHg despite medication (early hypotony with an IOP of
<5 mmHg at 1 week postoperatively was excluded), progression to
no light perception, or requirement of further surgical intervention
including needling bleb revision for the control of high IOP.
2.1. Description of device
The Ex-PRESS glaucoma ﬁltration device (Alcon Laboratories,
Fort Worth, TX, USA) is designed to drain aqueous ﬂuid from theanterior chamber to the subconjunctival space and form a ﬁltration
bleb, similar to TRBC. The Ex-PRESS glaucoma device is currently
available in two models: the R-model and the P-model.5
In this study, we used the P-2oo model for implantation. The P-
2oomodel has a length of 2.64 mm, a decreased bevel angle, and an
internal and external lumen diameter of 200 and 400 mm,
respectively.
2.2. Ex-PRESS surgical technique
All patients received retrobulbar anesthesia, and a single limbal-
based conjunctival incisionwas performed prior to gentle exposure
of the scleral bed. Scleral ﬂaps of approximately 2  2 mm were
created in a similar manner to standard TRBC, and antiﬁbrotic
agents (mitomycin C) were applied. Variable concentrations and
durations of mitomycin C treatment are commonly used. A con-
centration of 0.2 mg/mL was used in this study. Application time
varied between 1 and 5 minutes depending on the preoperative
IOP, the age of the patient, and the condition of the capsule of
Tenon. For example, in patients at high risk of unsuccessful ﬁltering
surgery, such as thosewith high preoperative IOP, or with increased
thickness of the capsule of Tenon, mitomycin C was applied for
5minutes. However, in young patients, the duration of mitomycin C
application may be 1 minute for the prevention of postoperative
hypotony and further scleral malacia.
When sclerectomy or iridectomy was not required, a 25-gauge
needle was used to access the anterior chamber at the point
midway along the base of the scleral ﬂap and then removed gently
to avoid lateral movement that may extend the channel and cause
aqueous humor to leak around the shunt. The Ex-PRESS shunt is
preloaded on an injector. The shunt is introduced into the anterior
chamber exclusively through the ostium created by the needle and
released by applying pressure to the shaft of the inserter. The scleral
ﬂap is then sutured with 9e0 Nylon and with the tightness
adjusted depending on the resultant ﬂow during inﬂation of the
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needle through the temporal paracentesis. Finally, the conjunc-
tival incision was closed using a 10e0 Nylon.
Ex-PRESS surgery can be learned easily, particularly by doctors
with previous TRBC experience.Fig. 2. Both procedures showed good control of intraocular pressure (IOP). However,
there was no statistical difference (p ¼ 0.286) between the two groups.
Fig. 3. After both procedures, the number of antiglaucoma medications prescribed was
signiﬁcantly decreased, although there was no statistical difference observed
(p ¼ 0.285).3. Results
A total of 33 patients with unilateral POAG were enrolled and
were separated into following two groups according to patient
choice: the TRBC group (17 patients, Group A) and the Ex-PRESS
group (16 patients, Group B). All patients received regular
ophthalmology outpatient department assessments at 1 and
3 days, 1 and 2 weeks, and 1, 3, 6, and 12 months postoperatively.
No signiﬁcant differences were observed between the two groups
(Table 1), other than the signiﬁcantly higher age of patients in the
TRBC group as compared to the Ex-PRESS group. Preoperatively, the
mean IOP values were 38.5 (±6.9) mmHg in Group A and 38.5 (±9.1)
mmHg in Group B. At 12 months follow up, the mean IOP values
were 18.2 (±11) mmHg in Group A and 19.53 (±12.36) mmHg in
Group B. Both groups had signiﬁcant reductions in IOP following
surgery (p < 0.01). A signiﬁcant reduction in the number of anti-
glaucoma medications was also observed in both groups post-
operatively with reductions ranging from 3.2 (±0.5) to 1.2 (±1.4),
and 3.3 (±0.7) to 1 (±0.9), following TRBC and Ex-PRESS implan-
tation, respectively (p < 0.01 for both). The results regarding the
evolution of IOP and the number of medications taken in both
groups are presented in Figs. 2 and 3.
At 1-year follow up, eight out of 17 patients (47%) in Group A,
and seven out of 16 patients (43%) in Group B, achieved complete
success, which was deﬁned as being medication-free with IOP be-
tween 5 and 18 mmHg. Qualiﬁed success, deﬁned as IOP >5 and
<18 mmHg with or without antiglaucoma medication, was
observed in 13 out of 17 (76.47%) patients in Group A and 12 out of
16 (75.00%) patients in Group B.
Complications were generally mild, and the complication rate
was similar between the groups (Table 2). However, the incidence
of early hypotony on Day 1 was much higher in patients receiving
Ex-PRESS surgery (17.64% in Group A vs. 37.5% in Group B); how-
ever, these complications were self-limited and resolved within
1 week. TRBC resulted in hyphema in two patients and bleb leakage
in one patient with all recovering spontaneously within 1 week
after treatment with medication or pressure gauze. There were no
occurrences of conjunctival erosion or choroidal detachment in
either group. No patients required further surgical interventions.Table 1
Patient demographics and characteristics.
TRBC group
Sex N
Male 11
Female 6
Age
Mean 63.76 ± 13.37
Range 29e80
Diagnosis
POAG 17
Preoperative IOP (mean ± SD) 38.5 ± 6.9
Range 28.5e48.5
Preoperative medication number (mean ± SD) 3.17 ± 0.5
Postoperative IOP at 12 mo (mean ± SD) 18.2 ± 11.0
Range 6e45
Postoperative medication number at
12 mo (mean ± SD)
1.2 ± 1.38
No signiﬁcant differences were found between the two groups, except for the fact that p
IOP ¼ intraocular pressure; POAG ¼ primary open angle glaucoma; SD ¼ standard deviaDuring the follow-up period, no acceleration in cataract for-
mation was encountered following either interventions, and visual
acuity remained unchanged relative to preoperative values.
4. Discussion
To our knowledge, this is the ﬁrst retrospective study comparing
TRBC with Ex-PRESS device implantation for the control of IOP inEx-PRESS group p
% N %
65 8 50 0.44
35 8 50
52.75 ± 12.2 0.01*
34e71
16 > 0.99
38.5 ± 9.1 0.50
27.5e48.5
3.31 ± 0.68 0.27
19.5 ± 12.4 0.28
8e46
0.94 ± 0.97 0.28
atients in the TRBC group were older compared with those in the Ex-PRESS group.
tion; TRBC ¼ trabeculectomy.
Table 2
Comparison of complications between trabeculectomy and Ex-PRESS.
Complications Trabeculectomy
n (%)
Ex-PRESS
n (%)
p
Shallow AC 4/17 (24%) 1/16 (6%) 0.335
Bleb leak 1/17 (6%) 0/16 (0%) > 0.99
Hypotony 3/17 (17.64%) 6/16 (37.5%) 0.258
Hyphema 2/17 (12%) 0/16 (0%) 0.48
Choroidal detachment 0/17 (0%) 0/16 (0%) > 0.99
At least one complication 5/17 (29%) 6 (37.5%) 0.72
At least one complication
but exclude hypotony
4/17 (24%) 1 (6%) 0.335
In our study, the hypotony rate was much higher in the Ex-PRESS group (37.5% vs.
17.64%). If we excluded the hypotony condition in both groups, the TRBC group
showed higher postoperative complication rate than the Ex-PRESS group (24% vs.
6%). However, complications in both groups were mild and self-relieved within
1 week. p value was calculated using Fisher exact test.
AC ¼ anterior chamber; TRBC ¼ trabeculectomy.
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IOP in POAG. However, owing to the unavoidable risk of a number
of sight-threatening complications, surgeons have continued to
search for safer andmore efﬁcacious procedures than TRBC. The Ex-
PRESS device is a glaucoma drainage device developed within the
past two decades as an alternative to standard TRBC.
In our study, both procedures provided good control of IOP. The
qualiﬁed success rate was high in both groups A and B (76.5% and
75%), and the complete success rate was similar between the two
groups (47% vs. 43%). These ﬁndings corroborate a number of pre-
vious studies.6e8 In 2007, Maris et al6 published the 1-year follow-
up results of a retrospective series comparing Ex-PRESS with TRBC
and demonstrated a success rate (deﬁned as IOP>5 and<21mmHg)
of 90% in patients undergoing Ex-PRESS surgery and 92% in patients
undergoing TRBC. However, other studies have reported differing
results.9e11 The tube versus TRBC study9 revealed that the overall
success rate (deﬁned as IOP>4 and<18mmHg) inpatients receiving
the Ex-PRESS tube (82%) was higher than that in patients under-
going TRBC (66%) at 36months follow up. This discrepancywith our
study may relate to our follow-up period. A slow decline in TRBC
success is common. Beckers et al12 reported that the success rate
(deﬁned as an IOP<15mmHg) following TRBC is 83.3% at 12months
follow up, and this ﬁgure decreased to 60% at 72 months follow up.
Wilensky and Chen13 also reported a success rate (deﬁned as
IOP < 21 mmHg, or a decrease of 33% if the preoperative IOP was
<21 mmHg) following TRBC of 83% at 60 months, which decreased
to 73% at 120 months, and further decreased to 42% at 180 months.
Complications in both groups during our study were mild
(Table 2). However, the Ex-PRESS group had a higher total compli-
cation rate compared to the TRBC group (37.5% vs. 29%) as an
increased frequency of hypotony was observed in the Ex-PRESS
group (37.5% vs. 17.64%). Hypotony was self-limited and resolved
within 1weekwithout requirement of further surgical interventions
or occurrence of hypotonous maculopathy in both groups. If
hypotony cases in both group are excluded, the TRBC group had a
higher adjusted postoperative complication rate than the Ex-PRESS
group (24% vs. 6%). When compared with previous studies,6,7 the
hypotony rate was signiﬁcantly higher in our study. This result may
be attributed to the choice of Ex-PRESS model. The Ex-PRESS P-2oo
model, which has an internal lumen diameter of 200 mm, may have
provided overabundant ﬁltration of aqueous humor. The choice of
the Ex-PRESS R-50 or P-50 model, with a smaller internal lumen
diameter of 50 mm, may have decreased the incidence of hypotony.The number of glaucoma medications taken postoperatively
was lower than the number of glaucoma medications taken pre-
operatively (0.94 ± 0.96 vs. 1.18 ± 1.38). However, there was no
statistical difference between the two groups (p ¼ 0.286).
Visual acuity may alter as a result of improvement following
surgery or disease progression. In our study, equivalent visual
function following the surgery was observed in the majority of
patients with no statistical difference observed (p > 0.05). Maris
et al6 reported that 16% of patients undergoing TRBC, and 20% of
those undergoing Ex-PRESS surgery, lost two or more Snellen lines
(p ¼ 0.603). Good and Kahook7 reported increased visual recovery
following surgical intervention in patients undergoing Ex-PRESS
surgery but did not ﬁnd a signiﬁcant difference in visual acuity
between groups at 1 year.
Themajor limitation of our study is the small sample size, with a
total of 33 eyes in 33 patients. Furthermore, this study was not a
randomized controlled trial. The follow-up time of this study was
insufﬁcient as the success rate of ﬁltration surgery may decrease
over time. However, our study demonstrated similar results
compared to previous studies.
5. Conclusion
The present study is a retrospective study comparing TRBC and
Ex-PRESS implantation in Taiwanese patients. Both procedures
provided good control of IOP and reduced the number of post-
operative medications with a low incidence of postoperative
complications requiring further surgical interventions over an
intermediate-term follow-up period. However, although the effect
of Ex-PRESS implantation device may have longer duration, it is
more expensive than the other treatment options. Thus, it is up to
the surgeon to select the most appropriate procedure based on the
clinical and economic situation of individual patients.
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